Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML
Clinical trial NCT06156579 · RECRUITING
Trial details
- NCT number
- NCT06156579
- Sponsor
- University Hospital Tuebingen
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-04
- Primary completion
- 2026-09-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.